Claudia Ashleigh

Claudia Ashleigh Limited

ActiveLatest figures: 2025Abridged accountsCompany only23 years on the register

Private limited company registered in Romsey, classed under “Other human health activities”.

Headline figures

FY to Nov 2025 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

2 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

Pro

Every figure for all 5 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

From the filed balance sheets · £

Balance sheet	2022	2023	2024	2025
Fixed assets
Current assets
of which debtors
of which cash
Creditors due within a year
Net current assets
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year
Cash ratioCash for every £1 owed within a year
Creditors to assetsEverything owed to creditors as a share of fixed plus current assets

7 balance-sheet lines and 3 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

›What does Claudia Ashleigh do?

Private limited company registered in Romsey, classed under “Other human health activities”.

›How much turnover does Claudia Ashleigh make?

Answered in the full report

›Is Claudia Ashleigh profitable?

Claudia Ashleigh's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Claudia Ashleigh?

Answered in the full report

›Where is Claudia Ashleigh based?

Its registered office is Suite 7, 2 Park Court, Premier Way, Romsey, Hampshire, SO51 9DN, in Romsey, Hampshire.

›When was Claudia Ashleigh founded?

Claudia Ashleigh Limited was incorporated on 19 November 2002.

›Is Claudia Ashleigh still trading?

The register lists Claudia Ashleigh Limited as active.